Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have been widely used for disease modeling and drug cardiotoxicity screening. To this end, we recently developed human cardiac organoids (hCOs) for modeling human myocardium. Here, we perform a transcriptomic analysis of various in vitro hiPSC-CM platforms (2D iPSC-CM, 3D iPSC-CM and hCOs) to deduce the strengths and limitations of these in vitro models. We further compared iPSC-CM models to human myocardium samples. Our data show that the 3D in vitro environment of 3D hiPSC-CMs and hCOs stimulates the expression of genes associated with tissue formation. The hCOs demonstrated diverse physiologically relevant cellular functions compared to the hiPSC-CM only models. Inclu...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...
Background Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs) offer a promisin...
Animal models have proven integral to broadening our understanding of complex cardiac diseases but h...
Animal models have proven integral to broadening our understanding of complex cardiac diseases but h...
Genetic cardiomyopathies are characterized by changes in the function and structure of the myocardiu...
Genetic cardiomyopathies are characterized by changes in the function and structure of the myocardiu...
Human induced pluripotent stem cells (hiPSCs) can be used to generate various cell types in the huma...
Human cardiac drug discovery and disease modeling face challenges in recapitulating cellular complex...
Human cardiac drug discovery and disease modeling face challenges in recapitulating cellular complex...
Cardiovascular disease (CVD) is the most prevalent health problem in the world, and the high mortali...
The advent of human pluripotent stem cells (hPSCs) presented a new paradigm to employ hPSC-derived c...
Cardiac disease causes 33% of deaths worldwide but our knowledge of disease progression is still ver...
Cardiac disease causes 33% of deaths worldwide but our knowledge of disease progression is still ver...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...
Background Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs) offer a promisin...
Animal models have proven integral to broadening our understanding of complex cardiac diseases but h...
Animal models have proven integral to broadening our understanding of complex cardiac diseases but h...
Genetic cardiomyopathies are characterized by changes in the function and structure of the myocardiu...
Genetic cardiomyopathies are characterized by changes in the function and structure of the myocardiu...
Human induced pluripotent stem cells (hiPSCs) can be used to generate various cell types in the huma...
Human cardiac drug discovery and disease modeling face challenges in recapitulating cellular complex...
Human cardiac drug discovery and disease modeling face challenges in recapitulating cellular complex...
Cardiovascular disease (CVD) is the most prevalent health problem in the world, and the high mortali...
The advent of human pluripotent stem cells (hPSCs) presented a new paradigm to employ hPSC-derived c...
Cardiac disease causes 33% of deaths worldwide but our knowledge of disease progression is still ver...
Cardiac disease causes 33% of deaths worldwide but our knowledge of disease progression is still ver...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...
In the last decade, the generation of cardiac disease models based on human-induced pluripotent stem...